Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.

Hawai‘i strains S gene genomic characterization phylogenetic tree proline single nucleotide polymorphism spike protein variant

Journal

Hawai'i journal of health & social welfare
ISSN: 2641-5224
Titre abrégé: Hawaii J Health Soc Welf
Pays: United States
ID NLM: 101750601

Informations de publication

Date de publication:
01 03 2021
Historique:
entrez: 15 3 2021
pubmed: 16 3 2021
medline: 23 3 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has ravaged the world, caused over 1.8 million deaths in its first year, and severely affected the global economy. Hawai'i has not been spared from the transmission of SARS-CoV-2 in the local population, including high infection rates in racial and ethnic minorities. Early in the pandemic, we described in this journal various technologies used for the detection of SARS-CoV-2. Herein we characterize a 969-bp SARS-CoV-2 segment of the S gene downstream of the receptor-binding domain. At the John A. Burns School of Medicine Biocontainment Facility, RNA was extracted from an oropharyngeal swab and a nasal swab from 2 patients from Hawai'i who were infected with SARS-CoV-2 in August 2020. Following PCR, the 2 viral strains were sequenced using Sanger sequencing, and phylogenetic trees were generated using MEGAX. Phylogenetic tree results indicate that the virus has been introduced to Hawai'i from multiple sources. Further, we decoded 13 single nucleotide polymorphisms across 13 unique SARS-CoV-2 genomes within this region of the S gene, with 1 non-synonymous mutation (P681H) found in the 2 Hawai'i strains. The P681H mutation has unique and emerging characteristics with a significant exponential increase in worldwide frequency when compared to the plateauing of the now universal D614G mutation. The P681H mutation is also characteristic of the new SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally, several mutations resulting in cysteine residues were detected, potentially resulting in disruption of the disulfide bridges in and around the receptor-binding domain. Targeted sequence characterization is warranted to determine the origin of multiple introductions of SARS-CoV-2 circulating in Hawai'i.

Identifiants

pubmed: 33718878
pii: 2641-5224-80-3-2
pmc: PMC7953241

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-61

Commentaires et corrections

Type : UpdateOf

Informations de copyright

©Copyright 2021 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Déclaration de conflit d'intérêts

None of the authors identify a conflict of interest.

Références

Adv Drug Deliv Rev. 2021 Mar;170:1-25
pubmed: 33359141
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Cell Rep Med. 2020 Jun 23;1(3):100036
pubmed: 32835302
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
BMC Infect Dis. 2020 Dec 7;20(1):930
pubmed: 33287717
ACS Omega. 2020 Jun 23;5(26):16292-16298
pubmed: 32656452
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Mol Biol Evol. 2020 Apr 1;37(4):1237-1239
pubmed: 31904846
Virol Sin. 2020 Jun;35(3):337-339
pubmed: 32198713
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):200-209
pubmed: 32242873
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
J Med Virol. 2020 Jun;92(6):667-674
pubmed: 32167180
Hawaii J Health Soc Welf. 2020 May 1;79(5):136-142
pubmed: 32432217
Int J Hypertens. 2012;2012:307315
pubmed: 22121476
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15193-15199
pubmed: 32522874
J Biol Chem. 2019 May 17;294(20):8064-8087
pubmed: 30824541
Curr Biol. 2020 Aug 3;30(15):R849-R857
pubmed: 32750338
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

David P Maison (DP)

Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, CMS, VRN).
Pacific Center for Emerging Infectious Diseases Research, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, VRN).

Lauren L Ching (LL)

Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, CMS, VRN).
Pacific Center for Emerging Infectious Diseases Research, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, VRN).

Cecilia M Shikuma (CM)

Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, CMS, VRN).
Hawai'i Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (CMS).

Vivek R Nerurkar (VR)

Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, CMS, VRN).
Pacific Center for Emerging Infectious Diseases Research, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (DPM, LLC, VRN).

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH